Peer Reviewed
Immunisation update

Influenza: time to vaccinate but who and why?

Alan W Hampson
Abstract
Influenza vaccination should be recommended not only to all patients who qualify for the government-funded vaccine but also to those shown to be at increased risk of complications in the 2009-10 influenza pandemic, including the clinically obese and tobacco smokers.
Key Points
    The impact of influenza

    William Farr, a doctor and statistician in the British Office of the Registrar-General, first described the phenomenon of influenza-associated excess mortality as early as 1847. This excess mortality significantly outweighs that attributed to influenza itself. The true mortality burden of the disease is not obvious, is difficult to tease out, and is still largely unappreciated by the general population and, sometimes, by healthcare workers.

    Most influenza-associated mortality occurs in older adults and a significant proportion is recorded as being due to cardiovascular and cerebrovascular events. However, such deaths do not only occur in the older adult group, and at least one study found that influenza-related ischaemic heart disease deaths occurred mostly in the 40- to 64-year-old age group. Unfortunately, mortality is only a small part of the overall burden of influenza to the Australian healthcare system.

Get full access
Subscribe for full access to all articles
Buy this article

Single article purchases are temporarily unavailable due to site maintenance.

If you would like to purchase an article during this time, please email us at [email protected] with the article details and we'll assist you directly. We'll also let you know when online purchasing is available again.

Thank you for your patience and understanding.

Already a subscriber?